
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Grass Pollen Induced Allergic Rhinoconjunctivitis
View Full LandscapeTarget Indication
Grass Pollen Induced Allergic Rhinoconjunctivitis
Clinical Trial
NCT02166268Last updated: 6/28/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Asthma
Allergic Rhinoconjunctivitis
Allergy
Allergic Rhinitis Due to Dermatophagoides Farinae
Rhinitis Allergic